Innovative clinical trial designs for future antiepileptic drugs

Epilepsia

Volumn 48, Issue SUPPL. 1, 2007, Pages 26-30

  Dichter, Marc A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AED; Antiepileptic drug; Clinical trial design; Intervention strategies; Pharmacoresistance; Prevention; Refractory epilepsy; Seizure; Treatment strategies

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN; VALPROIC ACID;

ALZHEIMER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DEMENTIA; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; HUMAN; INCIDENCE; MEDICAL PRACTICE; NONHUMAN; PHYSICIAN; PRIORITY JOURNAL; SEIZURE; TRAUMATIC BRAIN INJURY;

ANTICONVULSANTS; CLINICAL TRIALS; DRUG RESISTANCE; EPILEPSY; FORECASTING; HUMANS; RESEARCH DESIGN;

EID: 33847116238     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.00996.x     Document Type: Conference Paper

References (18)

1. Cramer JA, Fisher R, Ben-Menachem E, et al. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999;40:590-600.
2. Callaghan BC, French JA, Anand K, et al. Treatment changes associated with remission in a refractory adult epilepsy population. Epilepsia 2005;5(6C):S594.
3. Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005;6:591-602.
4. Remy S, Gabriel S, Urban BW, et al. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 2003;53:469-79.
5. French J, Temkin N, Nye J, et al. Time to nth seizure vs seizure frequency reduction as efficacy endpoints in AED trials: observations from topiramate (TPM) data (abstract). Epilepsia, 2006; in press.
6. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
7. Musicco M, Beghi E, Solari A, et al. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 1997;49:991-8.
8. Camfield PR, Camfield CS, Dooley JM, et al. Long-term outcome is unchanged by anti-epileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood. Epilepsia 2002;43:662-3.
9. Fisher RS van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2.
10. Temkin NR, Dikmen SS, Winn HR. Management of head injury. Posttraumatic seizures. Neurosurg Clin N Am 1991;2:425-35.
11. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
12. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593-600.
13. Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998;338:20-4.
14. Lewis DV. Febrile convulsions and mesial temporal sclerosis. Curr Opin Neurol 1999;12:197-201.
15. Shorvon S. Does convulsive status epilepticus (SE) result in cerebral damage or affect the course of epilepsy-the epidemiological and clinical evidence? Prog Brain Res 2002:135:85-93.
16. D'Ambrosio R, Fairbanks JP, Fender JS, et al. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004;127:304-14.
17. Toth Z,Yan XX, Haftoglou S, et al. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 1998;18:4285-94.
18. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 2002;50:105-23.